Literature DB >> 18663373

The clinical outcomes after complete surgical resection of intramedullary cavernous angiomas: changes in motor and sensory symptoms.

S B Park1, T-A Jahng, C K Chung.   

Abstract

STUDY
DESIGN: Evaluation of the surgical effects of patients with intramedullary spinal cord cavernous angiomas (CAs).
OBJECTIVES: To assess the sensory and motor deficits in the clinical symptoms of patients with intramedullary CAs after complete surgical resection.
SETTING: Seoul National University Hospital, Korea.
METHODS: The authors reviewed 14 patients with intramedullary spinal cord CAs who underwent surgical resection between 1995 and 2006. The average follow-up duration was 55.0+/-45.1 months. To analyze the changes in the patients' symptoms after surgery, the ASIA (American Spinal Injury Association) and JOA (Japanese Orthopedic Association) scoring systems were used at different time points: preoperative, postoperative and during the final follow-up period.
RESULTS: The patients' mean ASIA score at follow-up was increased in comparison to the preoperative score (97.2+/-5.3 vs 95.2+/-7.6, P=0.201), but this difference was not significant. The mean JOA motor score at follow-up was slightly increased in comparison to the preoperative score (7.2+/-1.3 vs 6.8+/-1.3, P=0.107). There was a significant difference between the patients' preoperative and follow-up JOA sensory score (4.3+/-1.0 vs 4.9+/-0.9, P=0.007). The rates of complete resolution of motor and sensory deficits were 45.5% (5/11 patients) and 7.1% (1/14 patients), respectively.
CONCLUSION: Although complete surgical resection could improve the clinical symptoms of intramedullary CAs, the sensory deficits usually remain in the long-term period after complete resection.

Entities:  

Mesh:

Year:  2008        PMID: 18663373     DOI: 10.1038/sc.2008.89

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  7 in total

1.  Intra-operative high frequency ultrasound improves surgery of intramedullary cavernous malformations.

Authors:  Oliver Bozinov; Jan-Karl Burkhardt; Christoph M Woernle; Vincent Hagel; Nils H Ulrich; Niklaus Krayenbühl; Helmut Bertalanffy
Journal:  Neurosurg Rev       Date:  2011-11-12       Impact factor: 3.042

Review 2.  Cavernous malformations of central nervous system in pediatric patients: our single-centered experience in 50 patients and review of literature.

Authors:  Dattaraj Paramanand Sawarkar; Suveen Janmatti; Rajinder Kumar; Pankaj Kumar Singh; Hitesh Kumar Gurjar; Shashank Sharad Kale; Bhawani Shanker Sharma; Ashok Kumar Mahapatra
Journal:  Childs Nerv Syst       Date:  2017-06-20       Impact factor: 1.475

3.  Cauda equina cavernous hemangioma: very rare pediatric case.

Authors:  Kaan Yaltirik; Selçuk Özdoğan; Işın Doğan Ekici; Başar Atalay
Journal:  Childs Nerv Syst       Date:  2016-10-29       Impact factor: 1.475

4.  Validity of magnetic resonance imaging (MRI) in the primary spinal cord tumors in routine clinical setting.

Authors:  Young Il Won; Yunhee Choi; Woon Tak Yuh; Shin Won Kwon; Chi Heon Kim; Seung Heon Yang; Chun Kee Chung
Journal:  Sci Rep       Date:  2022-06-16       Impact factor: 4.996

5.  Intramedullary spinal cord cavernous malformations-association between intraoperative neurophysiological monitoring changes and neurological outcome.

Authors:  Sebastian Niedermeyer; Andrea Szelenyi; Christian Schichor; Joerg-Christian Tonn; Sebastian Siller
Journal:  Acta Neurochir (Wien)       Date:  2022-09-06       Impact factor: 2.816

Review 6.  Thoracic spinal cord cavernous angioma: a case report and review of the literature.

Authors:  Giovanni Grasso; Concetta Alafaci; Francesca Granata; Mariano Cutugno; Francesco Maria Salpietro; Francesco Tomasello
Journal:  J Med Case Rep       Date:  2014-08-08

7.  Conservative and Surgical Management of Spinal Cord Cavernous Malformations.

Authors:  Yu-Ichiro Ohnishi; Nobuhiko Nakajima; Tomofumi Takenaka; Sho Fujiwara; Shinpei Miura; Eisaku Terada; Shuhei Yamada; Haruhiko Kishima
Journal:  World Neurosurg X       Date:  2019-11-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.